Figure 4
(A) Comparison between healthy control and patients with esophageal cancer showed that C16orf89, AR, CKB, ADH1B, and NCAM1 were the top five genes that were significantly down regulated in patients with esophageal cancer. (B) Stage-wise incremental downregulation of leading genes in patients with esophageal cancer. (C) Comparison between healthy control and patients with stomach cancer showed that: GPX3, CLEC3B, CFD, GSN, and CCL14 were the top five genes that were significantly down regulated in patients with stomach cancer. (D) The stage-based analysis showed a differential downregulation of various genes based on the stage of the disease. (E) Stage-wise incremental downregulation of leading genes in patients with stomach cancer. (F) Stage-wise downregulation of leading genes in patients with stomach cancer.
